ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004